Filing Details
- Accession Number:
- 0001859061-23-000003
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-04-06 19:31:22
- Reporting Period:
- 2023-03-31
- Accepted Time:
- 2023-04-06 19:31:22
- Original Submission Date:
- 2023-03-31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840439 | Biomea Fusion Inc. | BMEA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859061 | A2A Pharmaceuticals, Inc. | 59 5Th Ave New York NY 10003 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-31 | 200,000 | $31.25 | 4,100,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64. Additional details of the individual transactions are available upon request.
Billionaire Hedge Funds
